Literature DB >> 15834451

Death by stress: natural IgM-induced apoptosis.

H P Vollmers1, S Brandlein.   

Abstract

Stress kills and hence should be avoided. On the other hand, stress induction can be used to remove malignant cells by inducing cellular suicide. Natural IgM antibodies act as first-line defense in immune surveillance. These antibodies selectively kill aberrant cells by using different apoptotic stress mechanisms. They can be isolated from patients but also from healthy donors by using the human hybridoma technology. They are components of the innate immunity, and, on the basis of specific screening methods, should also be detectable in any other individual. The three tumor-specific, apoptosis-inducing natural IgM antibodies described in this review are good examples for stress-induced apoptosis and nature's resourceful ways to fight malignant growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834451     DOI: 10.1358/mf.2005.27.3.890876

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  10 in total

1.  In vitro characterization of chemokine-loaded liposomes.

Authors:  Angel J Rubio; Xuemei Zhong; Tyrone M Porter
Journal:  Cogent Biol       Date:  2019-09-11

2.  The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation.

Authors:  Patrick Auguste; Lucia Fallavollita; Ni Wang; Julia Burnier; Andreas Bikfalvi; Pnina Brodt
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

3.  High level expression of functional human IgMs in human PER.C6 cells.

Authors:  Anna Tchoudakova; Frank Hensel; Alec Murillo; Bernie Eng; Marketa Foley; Lakee Smith; Frank Schoenen; Antonia Hildebrand; Arndt-René Kelter; Leodevico L Ilag; H Peter Vollmers; Stephanie Brandlein; Jane McIninch; John Chon; Gene Lee; Marco Cacciuttolo
Journal:  MAbs       Date:  2009-03-24       Impact factor: 5.857

Review 4.  Humoral innate immune response and disease.

Authors:  Stephanie N Shishido; Sriram Varahan; Kai Yuan; Xiangdong Li; Sherry D Fleming
Journal:  Clin Immunol       Date:  2012-06-18       Impact factor: 3.969

Review 5.  Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).

Authors:  Mariana Díaz-Zaragoza; Ricardo Hernández-Ávila; Rubí Viedma-Rodríguez; Diego Arenas-Aranda; Pedro Ostoa-Saloma
Journal:  Oncol Rep       Date:  2015-06-30       Impact factor: 3.906

6.  L2pB1 Cells Contribute to Tumor Growth Inhibition.

Authors:  Varuna Shibad; Ali Bootwala; Changchuin Mao; Hanna Bader; Hung Vo; Esther Landesman-Bollag; Conrad Guo; Angel Rubio; Richard Near; Wenda Gao; Sreekar Challa; Vennela Chukka; Jeffrey Gao; Avery Kelly; Tamar Landesman; Tyler VanHelene; Xuemei Zhong
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 7.  Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.

Authors:  Yasmine Lounici; Olivia Le Saux; Gabriel Chemin; Pauline Wajda; Sarah Barrin; Justine Berthet; Christophe Caux; Bertrand Dubois
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

8.  Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

Authors:  Ariane Desselle; Tanguy Chaumette; Marie-Hélène Gaugler; Denis Cochonneau; Julien Fleurence; Nolwenn Dubois; Philippe Hulin; Jacques Aubry; Stéphane Birklé; François Paris
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology.

Authors:  Leah Hennings; Cecile Artaud; Fariba Jousheghany; Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Cancers (Basel)       Date:  2011-11-11       Impact factor: 6.639

Review 10.  Carbohydrate-mimetic peptides for pan anti-tumor responses.

Authors:  Thomas Kieber-Emmons; Somdutta Saha; Anastas Pashov; Behjatolah Monzavi-Karbassi; Ramachandran Murali
Journal:  Front Immunol       Date:  2014-06-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.